Cytrim 500 Injection contains Cytarabine 500mg, a highly effective antimetabolite chemotherapy drug widely used in the management of acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), and certain lymphomas. It works by inhibiting DNA synthesis in rapidly dividing malignant cells, making it a key part of modern oncology treatment protocols.
The 500mg strength is frequently utilized in combination chemotherapy cycles, consolidation phases, and intermediate-dose leukemia treatment. Its proven clinical efficacy and predictable therapeutic response make it a trusted choice in cancer-care regimens across hospitals and specialized oncology centers.
For distributors and oncology-focused businesses, Cytrim 500 Injection is a high-demand medicine, consistently required in hematology units, cancer institutes, infusion centers, and multispecialty hospitals. Because leukemia treatment involves multi-cycle therapy, this product ensures consistent movement and strong repeat demand.
Including Cytrim 500 in your product lineup strengthens your oncology and hematology segment, opening opportunities in hospital procurement, pharmacy distribution, government tenders, export shipments, and third-party manufacturing. Its essential role in chemotherapy makes it a strategically valuable addition for pharmaceutical distributors.